13F-HR filed by Catalio Capital Management, LP
Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 45 holding rows worth $565,790,302.
- Accession
- 0001958125-26-000002
- Filer
- CIK 1958125
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 45 entries on the cover page, a total value of $565,790,302 stated on the cover page (in dollars after the unit check, H1), rows summing to $565,790,302 with VALUE read as dollars as filed, 13F file number 028-25237. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 289,312 | $35,510,155 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 647,899 | $34,947,672 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 360,428 | $34,366,810 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 410,700 | $31,414,443 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 25,923 | $27,858,930 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 653,572 | $26,933,702 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 119,265 | $25,432,069 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,196,807 | $25,144,915 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 120,840 | $25,007,838 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 29,797 | $22,999,410 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 252,901 | $17,589,265 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 360,340 | $16,683,742 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 258,381 | $16,417,529 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 187,048 | $15,945,842 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 27,209 | $15,410,089 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 62,273 | $14,266,122 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 821,195 | $13,336,207 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 98,514 | $13,285,105 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 257,465 | $12,796,011 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 5,491,866 | $12,082,105 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 331,849 | $12,042,800 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 698,996 | $11,596,344 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 564,461 | $10,295,769 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 156,109 | $10,178,307 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 519,715 | $10,165,625 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 110,427 | $8,769,008 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 714,501 | $8,674,042 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 294,360 | $8,206,757 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,446,254 | $7,708,534 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 288,345 | $6,900,096 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 267,058 | $6,676,450 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 136,958 | $5,533,103 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 162,550 | $3,738,650 | dollars as filed | |
| HEARTFLOW INC | 42238D107 | COM | 113,857 | $3,318,932 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 30,313 | $2,594,490 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 201,301 | $2,276,714 | dollars as filed | |
| BILLIONTOONE INC | 090168105 | CL A | 25,505 | $2,087,329 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 1,259,820 | $1,902,328 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,320,041 | $1,292,716 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 10,452 | $1,094,011 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 142,984 | $1,052,362 | dollars as filed | |
| METAGENOMI THERAPEUTICS INC | 59102M104 | COM | 528,993 | $856,969 | dollars as filed | |
| ATAIBECKLEY INC | N0731H103 | Equity | 196,858 | $805,149 | dollars as filed | |
| OUTSET MED INC | 690145206 | COM NEW | 118,279 | $438,815 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 14,718 | $157,041 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001958125-26-000002 | this filing | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001958125-26-000007 | base | 2026-09-02 |